| P50 | author | Zhuowei Yu | Q55602993 |
| | Zhijun Bao | Q55602999 |
| P2093 | author name string | Jin Li | |
| | Cheng Ma | |
| | Qingwei Ruan | |
| P2860 | cites work | High medical co-morbidity and family history of dementia is associated with lower cognitive function in older patients | Q37346253 |
| | Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. | Q37354657 |
| | Late-life depression, mild cognitive impairment, and dementia: possible continuum? | Q37682019 |
| | Dementia risk prediction in the population: are screening models accurate? | Q37760428 |
| | Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial | Q38041758 |
| | Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. | Q40265803 |
| | Decreased serum lipids in patients with probable Alzheimer's disease | Q42270835 |
| | Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. | Q43009240 |
| | Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease | Q43242111 |
| | Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease | Q43702743 |
| | Serum lipoprotein levels, statin use, and cognitive function in older women | Q43915654 |
| | Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians | Q44376798 |
| | Attempted decomposition of age-related influences on two tests of reasoning | Q44881819 |
| | Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses | Q45415934 |
| | Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. | Q45983783 |
| | Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis | Q46105396 |
| | High total cholesterol levels in late life associated with a reduced risk of dementia. | Q46505847 |
| | Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans | Q46639824 |
| | Inflammatory markers and cognition in well-functioning African-American and white elders | Q46884320 |
| | Serum high-density lipoprotein cholesterol levels and mortality in frail, community-living elderly. | Q46891315 |
| | The course of cognitive decline in older persons: results from the longitudinal aging study amsterdam | Q47247593 |
| | Inflammatory proteins in plasma and the risk of dementia: the rotterdam study | Q47591273 |
| | Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study | Q47839413 |
| | Increased apolipoprotein B serum concentration in Alzheimer's disease | Q48154876 |
| | Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo | Q48170277 |
| | The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase | Q48473978 |
| | Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging | Q48511420 |
| | Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder | Q48685612 |
| | A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study | Q48725577 |
| | Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study | Q48925880 |
| | Oxidative imbalance in different neurodegenerative diseases with memory impairment. | Q49043217 |
| | Interleukin-6 is associated with cognitive function: the Northern Manhattan Study | Q24541301 |
| | Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease | Q28268162 |
| | Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster | Q28289655 |
| | The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? | Q30341682 |
| | Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review | Q30617426 |
| | Mining biomarkers in human sera using proteomic tools | Q33196952 |
| | Hypertension, cognitive decline, and dementia: an epidemiological perspective | Q33284785 |
| | The apoAI-CIII-AIV gene cluster | Q34293909 |
| | Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease. | Q34299310 |
| | Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals | Q34305083 |
| | Long-term systemic inflammation and cognitive impairment in a population-based cohort | Q34336957 |
| | Peripheral inflammatory markers in amnestic mild cognitive impairment | Q34548819 |
| | Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review | Q34554320 |
| | HDL and cognition in neurodegenerative disorders. | Q34614842 |
| | Inflammatory markers in population studies of aging | Q34995451 |
| | Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease | Q35034130 |
| | Lipid metabolism in long-lived families: the Leiden Longevity Study | Q35080214 |
| | Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease | Q35099780 |
| | Nontraditional risk factors combine to predict Alzheimer disease and dementia | Q35104464 |
| | Excessive sleepiness is predictive of cognitive decline in the elderly | Q36147041 |
| | Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study | Q36246792 |
| | Lipid metabolism in cognitive decline and dementia | Q36367149 |
| | Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study | Q36613964 |
| | Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia | Q36638605 |
| | Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease | Q36932748 |
| | Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study | Q37035931 |
| | Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study | Q37051184 |
| | Apolipoprotein E, an important player in longevity and age-related diseases | Q37158781 |
| | Physical activity and better medication compliance improve mini-mental state examination scores in the elderly. | Q50618600 |
| | Serum high-density lipoprotein cholesterol levels correlate well with functional but not with cognitive status in 85-year-old subjects. | Q50759156 |
| | Serum lipid levels in patients with Alzheimer's disease. | Q50799464 |
| | Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. | Q50801899 |
| | Microvascular network alterations in the retina of patients with Alzheimer's disease. | Q50864313 |
| | Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. | Q50913733 |
| | Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. | Q50969897 |
| | Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. | Q51102458 |
| | Serum high-density lipoprotein cholesterol levels, their relationship with baseline functional and cognitive status, and their utility in predicting mortality in nonagenarians. | Q51819103 |
| | Plasma levels of apolipoprotein E and cognitive function in old age. | Q51904346 |
| | Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. | Q53226489 |
| | Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. | Q53236904 |
| | Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. | Q53250180 |
| | Apolipoprotein E as vascular risk factor in neurodegenerative dementia. | Q53264301 |
| | GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant. | Q53323978 |
| | Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. | Q53385146 |
| | GSTM1 null genotype as risk factor for late-onset Alzheimer's disease in Italian patients. | Q53652861 |
| | Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia | Q57589372 |
| | Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer's disease | Q70840305 |
| | Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group | Q73171412 |
| | Measurement of apolipoprotein E (apoE) in cerebrospinal fluid | Q73818777 |
| | Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity | Q73986445 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 481621 | |
| P577 | publication date | 2015-11-23 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men | |
| P478 | volume | 2015 | |